BioCentriq is the Cell and Gene Therapy Development Center at NJII. It is a state-of-the-art process development and cGMP manufacturing center equipped with two GMP suites for cell & gene therapy clinical production and a cell & gene therapy process development pilot plant.
Need process development or clinical manufacturing help for your cell or #genetherapy project? Customized training for your research staff? Our new video shows how we can help - Learn more at https://njii.com/biopharma/Posted by New Jersey Innovation Institute - NJII on Tuesday, May 5, 2020
BioCentriq is available for pre-competitive group sponsored projects and fee-for-service proprietary projects. We enable rapid growth of new scale-up and manufacturing technologies, customized as needed for each client. We also partner with those who want to develop and test new manufacturing technologies.
Our clients come to us for fast and cost effective development services that are secure, confidential and flexible. We do not retain any intellectual property, all IP belongs solely to the client.
Moving the Biopharmaceutical Industry Forward
In addition, we collaborate with many large pharmaceutical companies, training partners and funders such as the US government and the National Institute for Innovation in Manufacturing (NIIMBL) to educate the next generation workforce who want to provide general and customized training in cell therapy and biologics manufacturing.
BioCentriq is owned by NJII. Our mission as a 501(3)c not-for-profit corporation is to support the development of cell and gene therapies through innovation and collaboration.